[Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
A 62-year-old man with supraventricular/ventricular tachycardia associated with myocardial infarction developed tachycardia during beating coronary artery bypass grafting (CABG). Intravenous administration of an ultra short acting beta-blocker, landiolol hydrochloride, controlled heart rate and improved tachyarrhythmia without significant change of blood pressure. Landiolol hydrochloride is effective and useful for the treatment of tachyarrhythmia during beating CABG.
Shimomura
T
T
Division of Cardiovascular Surgery, Owari Prefectural Hospital, Ichinomiya, Japan.
Fujii
G
G
Suzuki
S
S
Miyahara
K
K
Matsuura
A
A
Yoshida
K
K
Kasamatsu
M
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001026:Coronary Artery Bypass / Q000379:methods; D006801:Humans; D007262:Infusions, Intravenous; D007431:Intraoperative Complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage*; D013610:Tachycardia / Q000188:drug therapy*; D016896:Treatment Outcome; D014508:Urea / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D000319:Adrenergic beta-Antagonists; D009025:Morpholines; C077049:landiolol; D014508:Urea